Bioluminescence Ventures’ Post

I'm excited to share a press release highlighting Thrive Bioscience, Inc.'s impactful participation at Cell Bio 2023, the prestigious American Society for Cell Biology (ASCB) meeting in Boston. Thrive's showcase, led by our esteemed and pedigreed CEO Thomas Forest Farb-Horch, was exceptionally well-received. The highlight was the introduction of CellAssist Software Release 5.0, a revolutionary product in cell biology. We're actively delivering this cutting-edge software to collaborators, aiming for full deployment by mid-2024. Release 5.0 marks a significant advance in cell biology research, offering groundbreaking features like precise, label-free cell counting and confluence measurement. These innovations, powered by quantitative phase imaging (QPI) and our proprietary algorithms, are set to transform cell-based therapy development and experimental research. Additionally, Thrive has enhanced Release 5.0 with a novel QPI-based imaging mode, improving data quality and visualization. This technology enables deeper insights into viral plaque formation, as evidenced by the praise from a top virologist who acknowledged its profound impact on virus research. Your investment in Thrive Bioscience is bearing fruit, significantly influencing global research. Success at Cell Bio 2023 is just the beginning of an exciting journey, made possible by your support and belief in Tom’s vision. We encourage you to review the press release for more details, which can be downloaded here: https://bit.ly/3NKk9ch #LifeSciencesInvesting #FamilyOfficeInvestment #DiagnosticInnovation #HealthcareTech #BiotechStartups #MedicalDiagnostics #VentureCapitalHealth #PrecisionMedicine #BiopharmaInvesting #HealthTechFunding

Discover how Arctoris can support you throughout your drug discovery journey - get in touch today!

Frontier Science - Chemoproteomics w/ Daniel Nomura - Professor @ University of California, Berkeley Tune into our enlightening podcast episode featuring Prof. Daniel Nomura from University of California, Berkeley. He discusses his transformative work at Frontier Medicines, where they're pioneering new frontiers in precision medicine by targeting elusive, disease-causing proteins. Prof. Nomura shares insights on chemoproteomics, covalent drug discovery, and the integration of machine learning to develop groundbreaking cancer treatments, especially targeting the KRAS G12C mutation. This episode offers a rare glimpse into the seamless blend of academic research and biotech entrepreneurship, driven by personal passion and scientific curiosity. 👉 Don't miss this deep dive into the innovative approaches reshaping drug discovery. https://buff.ly/47W13H5 Shoutout: The Column Group, Andreessen Horowitz, Droia Ventures, Vicinitas Therapeutics, University of California, San Francisco & more. #DrugDiscovery #PrecisionMedicine #ChemicalBiology #Biotech #InnovativeResearch

Frontier Science - Chemoproteomics w/ Daniel Nomura - Professor @ University of California, Berkeley Tune into our enlightening podcast episode featuring Prof. Dan Nomura from University of California, Berkeley. He discusses his transformative work at Frontier Medicines, where they're pioneering new frontiers in precision medicine by targeting elusive, disease-causing proteins. Prof. Nomura shares insights on chemoproteomics, covalent drug discovery, and the integration of machine learning to develop groundbreaking cancer treatments, especially targeting the KRAS G12C mutation. This episode offers a rare glimpse into the seamless blend of academic research and biotech entrepreneurship, driven by personal passion and scientific curiosity. 👉 Don't miss this deep dive into the innovative approaches reshaping drug discovery. https://lnkd.in/gK7yvqqQ Shoutout: The Column Group, Andreessen Horowitz, Droia Ventures, Vicinitas Therapeutics, University of California, San Francisco & more. #DrugDiscovery #PrecisionMedicine #ChemicalBiology #Biotech #InnovativeResearch

At the Longevity Workshop in collaboration with the Longevity Biotech Fellowship, Max Novendstern Worldcoin highlighted his work on developing in vitro organs through a tissue engineering lab aimed at making vital organs universally accessible. He emphasized three key premises: that organogenesis, or growing new organs, is an underrated but promising path to longevity; that in vitro development, where organs are grown in controlled environments, offers greater flexibility and scalability than other methods; and that current technological advancements make this endeavor feasible. While he explored alternatives like xenotransplantation and chimerism, he argued that in vitro development provides more control and long-term potential for improving human health. Please see the full recording here: https://lnkd.in/gQ6yzc6r

Frontier Science - Chemoproteomics w/ Dan Nomura - Professor @ University of California, Berkeley Tune into our enlightening podcast episode featuring Prof. Dan Nomura from University of California, Berkeley. He discusses his transformative work at Frontier Medicines, where they're pioneering new frontiers in precision medicine by targeting elusive, disease-causing proteins. Prof. Nomura shares insights on chemoproteomics, covalent drug discovery, and the integration of machine learning to develop groundbreaking cancer treatments, especially targeting the KRAS G12C mutation. This episode offers a rare glimpse into the seamless blend of academic research and biotech entrepreneurship, driven by personal passion and scientific curiosity. 👉 Don't miss this deep dive into the innovative approaches reshaping drug discovery. https://buff.ly/47W13H5 Shoutout: The Column Group, Andreessen Horowitz, Droia Ventures, Vicinitas Therapeutics, University of California, San Francisco & more. #DrugDiscovery #PrecisionMedicine #ChemicalBiology #Biotech #InnovativeResearch

Frontier Science - Supramolecular Biomaterials💥 w/ Eric Appel - Professor @ Stanford Join us as we explore Eric Appel's pioneering research on supramolecular hydrogels and their transformative potential in drug delivery and regenerative medicine. Eric discusses the development of advanced hydrogels for targeted cancer therapy and wound healing, and the innovative excipients his team is creating for protein therapeutics like insulin through his company, Surf Bio. Discover how these breakthroughs are not only enhancing therapeutic applications but also extending to wildfire prevention. Tune in for an in-depth look at the future of materials science and its real-world impact! Tune in:

Exciting news from Antleron! We're thrilled to announce the recent publication of our latest article, "Bayesian cell therapy process optimization," authored by our colleagues in collaboration with the Biovism lab at Ghent University. Published in Biotechnology and Bioengineering, this paper demonstrates how applying noisy Bayesian optimization to cell therapy process development can significantly reduce costs and improve process efficiencies. In short, we demonstrate: -      Up to 70% cost and time reduction compared to benchmark -      Doubling process efficiency, while maintaining high purity -      50% reduction in experimental effort Cell therapy process development traditionally relies heavily on physical experimentation due to the complexity of digital approaches. However, our research showcases how Bayesian optimization, rooted in machine learning and mathematical optimization principles, offers a revolutionary black-box approach. With minimal experimental input and no mechanistic knowledge required, this method presents a game-changing solution for cutting costs and timelines in process development. Check out the paper in the comments below, and don't hesitate to reach out to our Antleron experts to learn how we can implement Bayesian optimization to fast-track your bioprocess development! Evan Claes Tommy Heck Kathleen Coddens Maarten Sonnaert Jan Schrooten Jan Verwaeren Ghent University #processdevelopment #processoptimization #cellandgenetherapy #bioprocess #bayesianoptimization #bioprocessing

🚀 Exciting News! 🚀 🎉 We are thrilled to announce the newest addition to our Cell Family Wall: 𝗜𝗺𝗺𝗼𝗿𝘁𝗮𝗹𝗶𝘇𝗲𝗱 𝗛𝘂𝗺𝗮𝗻 𝗔𝗺𝗻𝗶𝗼𝘁𝗶𝗰 𝗘𝗽𝗶𝘁𝗵𝗲𝗹𝗶𝗮𝗹 𝗖𝗲𝗹𝗹𝘀!   Just like hanging a cherished photo to our wall at home, unveiling a new cell line is a moment of pride and excitement. This new member of our cell family represents countless hours of dedication, innovation, and teamwork. We can't wait to see the incredible discoveries and breakthroughs it will contribute to! 💡 𝗞𝗲𝘆 𝗕𝗲𝗻𝗲𝗳𝗶𝘁𝘀: • 𝗘𝘅𝘁𝗲𝗻𝗱𝗲𝗱 𝗟𝗶𝗳𝗲𝘀𝗽𝗮𝗻: Enhanced cell longevity to support long-term research projects • 𝗖𝗼𝗻𝘀𝗶𝘀𝘁𝗲𝗻𝘁 𝗣𝗲𝗿𝗳𝗼𝗿𝗺𝗮𝗻𝗰𝗲: Reliable and reproducible results for your critical experiments • 𝗩𝗲𝗿𝘀𝗮𝘁𝗶𝗹𝗲: Ideal for a wide range of applications including the establishment of in vitro models to study e.g. the barrier function of the placenta and perform toxicity studies A huge thank you to our dedicated team and partners for making this vision a reality.   #Evercyte #immortalizedcells #telomerizedcells #amnionepithelialcells #NewProductRelease Check out our newly released cells ➡ https://lnkd.in/dCAVtEvd Read the PR 📑https://lnkd.in/dVdaBBsH   #Evercyte #immortalizedcells #telomerizedcells #amnioticepithelialcells #NewProductRelease

Recapitulate biological enivronments with RASTRUM! #cellbiology #3Dcellmodeling #iPSCs #fibrosis #oncology #IO